123 related articles for article (PubMed ID: 16397274)
21. Helper T cell-independent proliferation of CD8+ cytotoxic T lymphocytes transduced with an IL-1 receptor retrovirus.
Nagoya S; Greenberg PD; Yee C; Weisser KE; Sugawara H; Widmer MB; Slack J; Dower SK; Lupton SD; Overell RW
J Immunol; 1994 Aug; 153(4):1527-35. PubMed ID: 8046231
[TBL] [Abstract][Full Text] [Related]
22. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
Pan JP; Weng YS; Wu QQ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
[TBL] [Abstract][Full Text] [Related]
23. Tumor secreting high levels of IL-15 induces specific immunity to low immunogenic colon adenocarcinoma via CD8+ T cells.
Araki A; Hazama S; Yoshimura K; Yoshino S; Iizuka N; Oka M
Int J Mol Med; 2004 Oct; 14(4):571-6. PubMed ID: 15375583
[TBL] [Abstract][Full Text] [Related]
24. IL-21 and IL-15 cytokine DNA augments HSV specific effector and memory CD8+ T cell response.
Rodrigues L; Nandakumar S; Bonorino C; Rouse BT; Kumaraguru U
Mol Immunol; 2009 Apr; 46(7):1494-504. PubMed ID: 19233474
[TBL] [Abstract][Full Text] [Related]
25. Ethanol consumption modifies dendritic cell antigen presentation in mice.
Heinz R; Waltenbaugh C
Alcohol Clin Exp Res; 2007 Oct; 31(10):1759-71. PubMed ID: 17850646
[TBL] [Abstract][Full Text] [Related]
26. [Immunotherapy for leukemia cells by using cytotoxic T lymphocyte specifically against WT1-derived peptide: an experimental study in vitro].
Gu WY; Cao XS; Qiu GQ; Chen ZX; Sheng LX; Xie XB; He J; Cen JN; Shen HL
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3475-80. PubMed ID: 16686063
[TBL] [Abstract][Full Text] [Related]
27. IL-6-transfected tumor cells modulate the status of CD8(+) and CD4(+) T cells to control tumor growth.
Hsieh CL; Liu SJ; Shen CR; Chen MY; Hsu SC; Tsai JP; Li YS; Yang CJ; Chong P; Chen HW
Immunobiology; 2010 Jun; 215(6):486-91. PubMed ID: 19699006
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of a potent tumor vaccine-induced secondary anti-tumor T cell response.
Mahnke YD; Schirrmacher V
Int J Oncol; 2004 Jun; 24(6):1427-34. PubMed ID: 15138584
[TBL] [Abstract][Full Text] [Related]
29. IL-4Ralpha signaling is important for CD8+ T cell cytotoxicity in the absence of CD4+ T cell help.
Marsland BJ; Schmitz N; Kopf M
Eur J Immunol; 2005 May; 35(5):1391-8. PubMed ID: 15816016
[TBL] [Abstract][Full Text] [Related]
30. Distinct phenotypes of antigen-selected CD8 T cells emerge at different stages of an in vivo immune response.
Walker PR; Ohteki T; Lopez JA; MacDonald HR; Maryanski JL
J Immunol; 1995 Oct; 155(7):3443-52. PubMed ID: 7561039
[TBL] [Abstract][Full Text] [Related]
31. AsialoGM1+CD8+ central memory-type T cells in unimmunized mice as novel immunomodulator of IFN-gamma-dependent type 1 immunity.
Kosaka A; Wakita D; Matsubara N; Togashi Y; Nishimura S; Kitamura H; Nishimura T
Int Immunol; 2007 Mar; 19(3):249-56. PubMed ID: 17229818
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic T lymphocyte recognition of secreted HLA class I molecules.
Kahn-Perles B; Barra C; Jehan J; Fourel D; Barad M; Maryanski JL; Lemonnier FA
J Immunol; 1989 May; 142(9):3021-5. PubMed ID: 2468709
[TBL] [Abstract][Full Text] [Related]
33. Central role of tumor-associated CD8+ T effector/memory cells in restoring systemic antitumor immunity.
Kilinc MO; Gu T; Harden JL; Virtuoso LP; Egilmez NK
J Immunol; 2009 Apr; 182(7):4217-25. PubMed ID: 19299720
[TBL] [Abstract][Full Text] [Related]
34. Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating endogenous CD49b-expressing CD4 and CD8 T effector cell subpopulations producing IL-10.
Dobrzanski MJ; Reome JB; Hylind JC; Rewers-Felkins KA; Abdulsamad K; Adams SL
Immunol Invest; 2008; 37(4):315-38. PubMed ID: 18569073
[TBL] [Abstract][Full Text] [Related]
35. [Therapeutic effects of treatment of pancreatic carcinoma by interleukin-23 and apoptotic cell antigen-modified dendritic cell vaccine: experiment with mice].
Tan G; Wang ZY; Yin S
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):943-6. PubMed ID: 16759530
[TBL] [Abstract][Full Text] [Related]
36. Induction of a distinct CD8 Tnc17 subset by transforming growth factor-beta and interleukin-6.
Liu SJ; Tsai JP; Shen CR; Sher YP; Hsieh CL; Yeh YC; Chou AH; Chang SR; Hsiao KN; Yu FW; Chen HW
J Leukoc Biol; 2007 Aug; 82(2):354-60. PubMed ID: 17505023
[TBL] [Abstract][Full Text] [Related]
37. Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.
Ye Z; Tang C; Xu S; Zhang B; Zhang X; Moyana T; Yang J; Xiang J
Cell Mol Immunol; 2007 Aug; 4(4):277-85. PubMed ID: 17764618
[TBL] [Abstract][Full Text] [Related]
38. Immune phenomena involved in the in vivo regression of fibrosarcoma cells expressing cell-associated IL-1alpha.
Dvorkin T; Song X; Argov S; White RM; Zoller M; Segal S; Dinarello CA; Voronov E; Apte RN
J Leukoc Biol; 2006 Jul; 80(1):96-106. PubMed ID: 16707560
[TBL] [Abstract][Full Text] [Related]
39. CD8+ cytotoxic T cells induce relapsing colitis in normal mice.
Nancey S; Holvöet S; Graber I; Joubert G; Philippe D; Martin S; Nicolas JF; Desreumaux P; Flourié B; Kaiserlian D
Gastroenterology; 2006 Aug; 131(2):485-96. PubMed ID: 16890603
[TBL] [Abstract][Full Text] [Related]
40. Redox modulation inhibits CD8 T cell effector function.
Sklavos MM; Tse HM; Piganelli JD
Free Radic Biol Med; 2008 Nov; 45(10):1477-86. PubMed ID: 18805480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
